Instrument Inactif

Gouvernance Immunomedics, Inc.

IMMU

US4529071080

Recherche biotechnologique et médicale

Comité Exécutif: Immunomedics, Inc.

Dirigeant

Fonctions occupéesDepuis

Brett Pletcher

58 ans

Corporate Secretary

23/10/2020

Composition du Conseil d'Administration: Immunomedics, Inc.

Administrateur

ComitésDepuis

Robert Musslewhite

56 ans

Governance Committee	12/12/2019
Nominating Committee	12/12/2019
Compensation Committee Chair	12/12/2019
Compensation Committee	07/03/2025
HR Committee	07/03/2025

Christina Carlson

Director/Board Member

23/10/2020

Brett Pletcher

58 ans

Director/Board Member

23/10/2020

Anciens Dirigeants et Administrateurs: Immunomedics, Inc.

Insider

Fonctions occupées

DepuisJusqu'au

Kurt J. W. Andrews

Human Resources Officer

01/07/2018

01/05/2021

Brendan Delaney

Corporate Officer/Principal

09/11/2017

01/01/2021

Usama Malik

Director of Finance/CFO	23/08/2018	01/12/2020
Corporate Officer/Principal	01/08/2017	23/08/2018

Jared M. Freedberg

General Counsel	24/09/2018	01/12/2020
Corporate Secretary	24/09/2018	01/12/2020

Chau Cheng

Investor Relations Contact	01/06/2004	01/12/2020
Corporate Secretary	01/06/2004	-

Behzad Aghazadeh

Chairman	03/03/2017	23/10/2020
Independent Dir/Board Member	03/03/2017	23/02/2019

Charles Baum

Director/Board Member	23/02/2019	23/10/2020
Independent Dir/Board Member	23/02/2019	23/10/2020

Peter Hutt

Director/Board Member	03/03/2017	23/10/2020
Independent Dir/Board Member	03/03/2017	23/10/2020

Robert Azelby

Director/Board Member

26/02/2020

23/10/2020

Barbara Duncan

Director/Board Member	05/03/2019	23/10/2020
Independent Dir/Board Member	05/03/2019	23/10/2020

Khalid Islam

Director/Board Member	03/03/2017	23/10/2020
Independent Dir/Board Member	03/03/2017	23/10/2020

Andrew Dickinson

Director/Board Member	23/10/2020	-
President	23/10/2020	-
Treasurer	23/10/2020	-

Scott Canute

Director/Board Member	03/03/2017	23/10/2020
Independent Dir/Board Member	03/03/2017	23/02/2019

William Fricker

Comptroller/Controller/Auditor

23/08/2018

01/10/2020

Harout Semerjian

Director/Board Member	16/04/2020	27/05/2020
Chief Executive Officer	16/04/2020	27/05/2020
President	16/04/2020	27/05/2020

Morris Z. Rosenberg

Chief Tech/Sci/R&D Officer

08/01/2018

15/05/2020

Loretta Itri

Chief Tech/Sci/R&D Officer

13/02/2020

Robert Iannone

Chief Tech/Sci/R&D Officer

09/04/2018

28/05/2019

Michael R. Garone

Chief Executive Officer	01/07/2017	09/11/2017
Director of Finance/CFO	21/06/2016	23/08/2018
Corporate Officer/Principal	23/08/2018	18/05/2019

Michael Pehl

Director/Board Member	07/12/2017	23/02/2019
Chief Executive Officer	09/11/2017	23/02/2019
President	07/12/2017	23/02/2019

Bryan Ball

Corporate Officer/Principal

01/02/2019

David M. Goldenberg

Director/Board Member	03/03/2017	02/04/2018
Chief Executive Officer	01/01/1982	01/01/1998
Chairman	01/01/1982	03/03/2017
Chief Tech/Sci/R&D Officer	01/01/1982	02/11/2017
Founder	01/01/1982	02/04/2018

Robert Oliver

Director/Board Member	09/01/2017	16/02/2017
Independent Dir/Board Member	09/01/2017	16/02/2017

Geoffrey F. Cox

Director/Board Member	09/01/2017	16/02/2017
Independent Dir/Board Member	09/01/2017	16/02/2017

Jason Aryeh

Director/Board Member	09/01/2017	16/02/2017
Independent Dir/Board Member	09/01/2017	04/02/2017

Robert M. Forrester

Director/Board Member	09/01/2017	16/02/2017
Independent Dir/Board Member	09/01/2017	16/02/2017

Don C. Stark

Director/Board Member	10/01/2005	09/01/2017
Independent Dir/Board Member	10/01/2005	09/01/2017

Mary E. Paetzold

Director/Board Member	01/01/2001	09/01/2017
Independent Dir/Board Member	01/01/2001	09/01/2017

Arthur Kirsch

Director/Board Member	19/08/2015	13/10/2016
Independent Dir/Board Member	19/08/2015	13/10/2016

Peter Pfreundschuh

Director of Finance/CFO

03/09/2013

01/09/2016

Richard Sherman

Director/Board Member	20/08/2013	02/12/2015
Independent Dir/Board Member	20/08/2013	02/12/2015

Marcella LoCastro

Director/Board Member	07/03/2012	04/12/2013
Independent Dir/Board Member	07/03/2012	04/12/2013

Morton Coleman

Director/Board Member

01/01/2000

04/12/2013

Gerard G. Gorman

Director of Finance/CFO

01/09/2001

03/09/2013

Kenneth Zuerblis

Director/Board Member	11/02/2010	08/03/2012
Independent Dir/Board Member	10/02/2010	08/03/2012

Edward T. Wolynic

Director/Board Member

01/08/2007

14/06/2010

Marvin E. Jaffe

Director/Board Member

27/08/2009

Richard R. Pivirotto

Director/Board Member

08/01/2007

Ivan Horak

Chief Tech/Sci/R&D Officer

01/05/2002

02/09/2005

Brian Markison

Director/Board Member	01/05/2004	-
Independent Dir/Board Member	01/05/2004	-

Sophie Visonneau

Corporate Officer/Principal

01/09/2001

01/04/2002

Shui On Leung

Corporate Officer/Principal

01/05/1991

01/07/2000

Robert de Luccia

Chief Executive Officer	01/01/1998	01/01/1999
President	01/01/1998	01/01/1999

Cynthia L. Sullivan

Director/Board Member	26/10/2010	-
Chief Executive Officer	19/10/2009	01/06/2017
President	19/10/2009	01/06/2017

Paul Herron

Director of Finance/CFO	01/01/1994	01/01/1997
Public Communications Contact	01/01/1994	01/01/1997

Rolf H. Henel

Chief Operating Officer

01/01/1996

01/01/1997

David Stack

Sales & Marketing

01/04/1993

01/05/1995

Russ C. McLauchlan

President

31/12/1991

Cynthia L. Goldenberg

President

01/01/1985

Melvin A. Snyder

Sales & Marketing

Hans J. Hansen

Chief Tech/Sci/R&D Officer	-	12/09/2012
Corporate Officer/Principal	12/09/2012	-

Bernhard Saxe

Corporate Secretary

Sandy Mohan

Corporate Officer/Principal

Wei Chen

Corporate Officer/Principal

John Zawad

Corporate Officer/Principal

Linda L. Nardone

Corporate Officer/Principal

John Landis

Director/Board Member

Rebecca A. Kinner

Public Communications Contact

22/10/2009

François E. Wilhelm

Chief Tech/Sci/R&D Officer

Phyllis Parker

Corporate Secretary

Ronald Falcone

Corporate Officer/Principal

Kent R. van Kampen

Director/Board Member

William A. Wegener

Chief Tech/Sci/R&D Officer

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	2
Femme	1

Dont comité exécutif

Homme	1
Femme	0

Dont Administrateurs

Homme	2
Femme	1

Immunomedics, Inc. est une société biopharmaceutique en phase clinique. La société est engagée dans le développement de produits à base d'anticorps monoclonaux pour le traitement ciblé du cancer. Ses technologies lui permettent de créer des anticorps humanisés qui peuvent être utilisés seuls, sous forme non marquée ou nue, ou conjugués à des isotopes radioactifs, des agents chimiothérapeutiques, des cytokines ou des toxines. Elle dispose d'un pipeline de six produits candidats au stade clinique. Son portefeuille de produits expérimentaux comprend des conjugués anticorps-médicament (ADC) qui sont conçus pour délivrer une charge utile d'un agent chimiothérapeutique directement à la tumeur, tout en gérant les effets toxiques globaux qui se produisent lors de l'administration conventionnelle de ces agents chimiothérapeutiques. Ses ADC sont le sacituzumab govitecan (IMMU-132) et le labetuzumab govitecan (IMMU-130). La société possède également une gamme d'autres produits candidats qui ciblent les tumeurs solides et les hémopathies malignes, ainsi que d'autres maladies, à divers stades de développement clinique et préclinique.

Employés

Secteur

Recherche biotechnologique et médicale

Plus d'informations sur la société